Back to search
FDAFDA · Food and drugs·Recall number Z-0252-2020

BD Vacutainer Eclipse Blood Collection Needles 22Gx1.25, cat. no. 368608

Published November 6, 2019 · Recall initiated: March 7, 2019

Summary

FDA records medical device Class II recall Z-0252-2020, published November 6, 2019 and initiated March 7, 2019. Recalling firm: Becton Dickinson & Company; Status: Terminated; Reported quantity: 2,624,160 (2,169,703 US; 454,457 OUS); Lot: Lot 8207894 ***UPDATED 7/11/19*** Lots 9025826 and 8354527 ***UPDATED 12/10/19*** Lot 9010765. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

BD PAS received customer complaints indicating the absence of the bevel on the non-patient needle end of the product, causing blood leakage.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Becton Dickinson & Company
Distributor
Distributed to accounts in AR, CT, FL, IL, IN, MI, MO, MS, NY, OH, TN, TX, and VA. Foreign distribution to Canada, Brazil, India, Mexico, Singapore, and Taiwan.
Lot
Lot 8207894 ***UPDATED 7/11/19*** Lots 9025826 and 8354527 ***UPDATED 12/10/19*** Lot 9010765
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was BD Vacutainer Eclipse Blood Collection Needles 22Gx1.25, cat. no. 368608 recalled?

Yes. FDA published recall Z-0252-2020 on November 6, 2019. Reported hazard: BD PAS received customer complaints indicating the absence of the bevel on the non-patient needle end of the product, causing blood leakage.

What should I do if I have this product?

Voluntary: Firm initiated · Letter